Ridazolol

Ridazolol
Nazivi
	IUPAC naziv 5-Hloro-4-[2-[[3-(2-hlorofenoksi)-2-hidroksipropil]amino]etilamino]-1H-piridazin-6-on
Identifikacija
3D model (Jmol)	interaktivna slika;
ChemSpider	64393;
PubChem C ID	71265;
	SMILES C1=CC=C(C(=C1)OCC(CNCCNC2=C(C(=O)NN=C2)Cl)O)Cl; ; ; ; ; ;
Svojstva
Hemijska formula	C15H18Cl2N4O3
Molarna masa	373,23 g·mol−1
	Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa).
	Reference infokutije

Ridazolol je antagonist beta adrenerginskog receptora.^[3]

Reference[уреди | уреди извор]

^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди
^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
^ Fach, WA; Starke, E; Becker, HJ (1992). „Duration of the effect and dose-response relationship of ridazolol in patients with coronary heart disease”. Zeitschrift für Kardiologie. 81 (6): 320—5. PMID 1353933.